87 Biggest Movers From Yesterday
Gainers
Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit.
Tinder Making It Easy For Users To Run Background Checks On Dates For Violence And Abuse
A leading dating app is making it easier for users to get background checks on matches before setting up dates.
Mid-Day Market Update: Nasdaq Surges 375 Points; Bumble Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq surging 375 points on Wednesday.
50 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sunshine Biopharma, Inc. (NASDAQ: SBFM) rose 148% to $3.78. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit.
Goldman Sachs Maintains Buy on Bumble, Lowers Price Target to $42
Goldman Sachs analyst Alexandra Steiger maintains Bumble (NASDAQ:BMBL) with a Buy and lowers the price target from $54 to $42.
Mid-Morning Market Update: Markets Open Higher; Dow Jumps Over 600 Points
U.S. stocks opened on a strong note this morning, with the Dow Jones jumping more than 600 points on Wednesday.
What 7 Analyst Ratings Have To Say About Bumble
Over the past 3 months, 7 analysts have published their opinion on Bumble (NASDAQ:BMBL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
So What’s Happening With Bumble Shares?
Bumble Inc (NASDAQ: BMBL) shares are trading higher by 22.0% at $20.32 after the company reported fourth-quarter results, which showed a 29% increase in Bumble App paying users. Bumble App revenue increased 42.2% year over year.
RBC Capital Maintains Outperform on Bumble, Lowers Price Target to $35
RBC Capital analyst Brad Erickson maintains Bumble (NASDAQ:BMBL) with a Outperform and lowers the price target from $55 to $35.